Skip to main content
logo
CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS · Delayed Price · Currency is USD
0.0034
+0.0001 (3.03%)
At close: Nov 6, 2026

CERO Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
011269236223
Market Cap Growth
20.24%-87.73%-83.24%-70.89%6.05%-
Enterprise Value
1791470236-
Last Close Price
0.000.07120.0022000.0020540.6019820.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
--0.26-6.081574.06-21.45-29.01

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.52-0.13-0.8367.45-0.06-
Net Debt / Equity Ratio
-0.490.160.8932.60-0.020.14
Net Debt / EBITDA Ratio
-0.850.050.11-0.20--
Quick Ratio
0.030.180.440.430.0211.20
Current Ratio
0.050.300.500.561.3813.88
Return on Assets (ROA)
-279.03%-253.00%-178.66%-20.20%-1.63%-
Return on Capital Employed (ROCE)
59.30%366.00%1355.00%-474.00%-25.00%-0.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-120044.41%-1409.96%-72.13%-10.61%-0.28%-0.24%
Buyback Yield / Dilution
-1854.15%-16477.89%----